7.94
price up icon0.51%   0.04
after-market Dopo l'orario di chiusura: 7.79 -0.15 -1.89%
loading
Precedente Chiudi:
$7.90
Aprire:
$7.855
Volume 24 ore:
958.39K
Relative Volume:
0.75
Capitalizzazione di mercato:
$322.66M
Reddito:
$128.29M
Utile/perdita netta:
$-30.69M
Rapporto P/E:
-9.6829
EPS:
-0.82
Flusso di cassa netto:
$-27.17M
1 W Prestazione:
+7.59%
1M Prestazione:
-42.04%
6M Prestazione:
-75.55%
1 anno Prestazione:
-83.40%
Intervallo 1D:
Value
$7.70
$7.975
Intervallo di 1 settimana:
Value
$7.24
$8.095
Portata 52W:
Value
$6.32
$58.23

Rxsight Inc Stock (RXST) Company Profile

Name
Nome
Rxsight Inc
Name
Telefono
949-521-7822
Name
Indirizzo
100 COLUMBIA STREET, ALISO VIEJO
Name
Dipendente
498
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
RXST's Discussions on Twitter

Confronta RXST con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
RXST
Rxsight Inc
7.94 321.03M 128.29M -30.69M -27.17M -0.82
Medical Devices icon
ABT
Abbott Laboratories
125.64 218.92B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.21 152.62B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
396.66 153.22B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.32 117.89B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
75.80 45.12B 5.54B 4.18B 623.10M 7.00

Rxsight Inc Stock (RXST) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-15 Downgrade Morgan Stanley Overweight → Equal-Weight
2025-07-10 Downgrade Jefferies Buy → Hold
2025-07-09 Downgrade BTIG Research Buy → Neutral
2025-07-09 Downgrade Oppenheimer Outperform → Perform
2025-07-09 Downgrade Wells Fargo Overweight → Equal Weight
2025-05-19 Aggiornamento Wells Fargo Equal Weight → Overweight
2025-04-15 Iniziato Piper Sandler Neutral
2025-04-09 Downgrade UBS Buy → Neutral
2025-04-04 Downgrade JP Morgan Overweight → Underweight
2025-04-03 Downgrade BofA Securities Buy → Underperform
2024-12-20 Downgrade Stifel Buy → Hold
2024-12-11 Downgrade Wells Fargo Overweight → Equal Weight
2024-12-06 Iniziato UBS Buy
2024-10-29 Iniziato Jefferies Buy
2024-08-20 Reiterato Needham Buy
2024-08-06 Reiterato Needham Buy
2024-05-07 Reiterato BTIG Research Buy
2023-12-13 Aggiornamento Wells Fargo Equal Weight → Overweight
2023-12-12 Iniziato Stifel Buy
2023-12-04 Iniziato Morgan Stanley Overweight
2023-04-13 Iniziato Oppenheimer Outperform
2022-12-12 Downgrade Wells Fargo Overweight → Equal Weight
2022-04-08 Iniziato Needham Buy
Mostra tutto

Rxsight Inc Borsa (RXST) Ultime notizie

pulisher
Jul 24, 2025

ROSEN, SKILLED INVESTOR COUNSEL, Encourages RxSight, Inc. - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Contact Levi & Korsinsky by September 22, 2025 to Join Class Action Against RxSight, Inc. (RXST) - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - The Globe and Mail

Jul 24, 2025
pulisher
Jul 24, 2025

Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - Benzinga

Jul 24, 2025
pulisher
Jul 24, 2025

RxSight Faces Class Action for Alleged Fraud - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

RXST CLASS ACTION: Decline in LAL Utilization leads to - GlobeNewswire

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about RxSight Inc. stockTriple-digit growth rates - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Medical Device Co. Faces Investor Suit Over Sales Decline - Law360

Jul 23, 2025
pulisher
Jul 23, 2025

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Is RxSight Inc. a good long term investmentSignificant capital appreciation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

RXST INVESTOR ALERT: RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Globe and Mail

Jul 23, 2025
pulisher
Jul 23, 2025

RXST ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of RxSight, Inc. Investors - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

RxSight, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

RXST LEGAL UPDATE: RxSight, Inc. Sued for Fraud Amid Declining LAL Utilization -- Investors with Losses are Notified to Contact BFA Law before September 22 Class Action Deadline - Business Wire

Jul 23, 2025
pulisher
Jul 23, 2025

What drives RxSight Inc. stock priceDynamic capital growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

RXST Investors with Losses in Excess of $100K Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - MarketScreener

Jul 23, 2025
pulisher
Jul 23, 2025

RxSight Investor Sues After 2025 Revenue Cut on Eye Device Sales - Bloomberg Law News

Jul 23, 2025
pulisher
Jul 23, 2025

Law Offices of Howard G. Smith Encourages RxSight, Inc. (RXST) Investors To Inquire About Securities Fraud Class Action - The Globe and Mail

Jul 23, 2025
pulisher
Jul 23, 2025

Rosen Law Firm Urges RxSight, Inc. (NASDAQ: RXST) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Globe and Mail

Jul 23, 2025
pulisher
Jul 23, 2025

RXSIGHT, INC. (NASDAQ: RXST) INVESTOR ALERT Investors With - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc.RXST - FinancialContent

Jul 23, 2025
pulisher
Jul 23, 2025

Shareholders Filed a Lawsuit Against RxSight for Overstating Demand - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

RxSight ($RXST) Sales Execution Failures, Guidance Cut, and Executive Turnover Case - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

Shareholder Alert: Robbins LLP Informs Investors of the RxSight,Inc. Securities Fraud Class Action Lawsuit - ACCESS Newswire

Jul 23, 2025
pulisher
Jul 22, 2025

RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

RXST LOSS ALERT: Lose Money on RxSight, Inc. (NASDAQ: - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights – RXST - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

RxSight Shares Fall 38% on Q2 ‘Underperformance’ - Orange County Business Journal

Jul 21, 2025
pulisher
Jul 21, 2025

RXST Investors Have Opportunity to Join RxSight, Inc. Fraud Investigation with the Schall Law Firm - ETX View

Jul 21, 2025
pulisher
Jul 20, 2025

RXST SECURITIES NEWS: Did RxSight, Inc. (NASDAQ:RXST) - GlobeNewswire

Jul 20, 2025
pulisher
Jul 19, 2025

RxSight Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Time To Worry? Analysts Just Downgraded Their RxSight, Inc. (NASDAQ:RXST) Outlook - simplywall.st

Jul 19, 2025
pulisher
Jul 19, 2025

What Does The Future Hold For RxSight, Inc. (NASDAQ:RXST)? These Analysts Have Been Cutting Their Estimates - Yahoo Finance

Jul 19, 2025
pulisher
Jul 19, 2025

Revenue Downgrade: Here's What Analysts Forecast For RxSight, Inc. (NASDAQ:RXST) - 富途牛牛

Jul 19, 2025
pulisher
Jul 18, 2025

Midday Stock Roundup: loanDepot Shoots Up 16% - Orange County Business Journal

Jul 18, 2025
pulisher
Jul 18, 2025

RXST INVESTIGATION: RxSight, Inc. (NASDAQ:RXST) 38% Stock - GlobeNewswire

Jul 18, 2025
pulisher
Jul 18, 2025

(RXST) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jul 18, 2025

Rxsight Inc Azioni (RXST) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$286.58
price down icon 0.03%
medical_devices STE
$227.25
price up icon 0.79%
medical_devices PHG
$25.84
price down icon 0.04%
$86.74
price up icon 0.36%
$76.77
price down icon 0.62%
medical_devices EW
$75.80
price down icon 1.44%
Capitalizzazione:     |  Volume (24 ore):